Windward Bio Group (WWB) News
NASDAQ: WWBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
24.29+0.275 (+1.15%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
WWB news summary
We found 5 recent headlines mentioning Windward Bio Group (WWB): 3 in the past week and 5 in the past 30 days, most often from PR Newswire, GlobeNewswire. For price context, WWB is up 1.15% at $24.29. The most recent story, "Windward Bio to Participate at the Jefferies London Global Healthcare Conference", was published by GlobeNewswire on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Windward Bio Group headlines
- Windward Bio to Participate at the Jefferies London Global Healthcare ConferenceBASEL, Switzerland, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG ("Windward") (Nasdaq: WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for…GlobeNewswire
- Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesBASEL, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Windward Bio Group AG ("Windward") (Nasdaq: WWB), a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for…GlobeNewswire
- Windward Bio Lists on Nasdaq, Shares Up 68% on DebutPivotal bioVenture Partners China-backed biotech built under the NewCo model on China-licensed assets debuts on Nasdaq less than two years after founding SHANGHAI, Nov. 16, 2026 /PRNewswire/ --…PR Newswire
- Innovative Immunology Biotech Windward Bio Lists on NasdaqSHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026.…PR Newswire
- Innovative Immunology Biotech Windward Bio Lists on NasdaqSHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026.…PR Newswire